Related Experiment Videos
[Circulating immune complexes in patients treated with Pollinex vaccine]
M Wrzyszcz1, J Małolepszy, M Krasnowska
1Katedry i Kliniki Chorób Wewnetrznych AM we Wrocławiu.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|September 3, 1990
Summary
Specific immunotherapy using Pollinex effectively desensitized patients with hay fever. This study found that Pollinex treatment does not lead to the formation of circulating immune complexes in patients undergoing immunotherapy for allergic rhinitis.
Area of Science:
- Immunology
- Allergology
Context:
- Rhinitis, commonly known as hay fever, affects a significant portion of the population.
- Current treatments for rhinitis include avoidance, pharmacotherapy, and immunotherapy.
- Pollinex is a specific immunotherapy agent used for desensitization in allergic rhinitis.
Purpose:
- To investigate the potential for circulating immune complexes (CICs) formation during specific immunotherapy with Pollinex in patients with allergic rhinitis.
- To evaluate the safety profile of Pollinex immunotherapy concerning CICs generation.
Summary:
- Twenty-six patients diagnosed with rhinitis underwent desensitization treatment using Pollinex.
- Circulating immune complexes were measured before and after immunotherapy using two distinct assay techniques: precipitation and Polyethylene Glycol-Circulating Immune Complex Test (PEG-CCT).
- The findings indicate that specific immunotherapy with Pollinex does not lead to the formation of circulating immune complexes in patients suffering from hay fever.
Impact:
- Provides crucial safety data regarding Pollinex immunotherapy for allergic rhinitis.
- Suggests that Pollinex immunotherapy is a safe treatment option concerning immune complex formation.
- Contributes to the understanding of the immunological response to specific immunotherapy in allergic diseases.